## Summary
This paper proposes TrajGPT, a pre-trained model for irregularly sampled clinical event sequences. Its core ideas are a Selective Recurrent Attention (SRA) mechanism with content-dependent decay and a time-specific inference procedure motivated by an ODE interpretation, with experiments on PopHR and eICU spanning forecasting and several clinical prediction tasks.

## Strengths
- **Important problem and relevant setting.** Irregularly sampled longitudinal EHR data is a real modeling challenge, and the paper directly targets this setting rather than assuming regular sampling.
- **Plausible modeling contribution.** The SRA update
  \[
  S_n=\gamma_n S_{n-1}+K_n^\top V_n,\quad \gamma_n=\sigma(X_n w_\gamma^\top)^{1/\tau}
  \]
  is a sensible way to combine recurrent/linear-attention style state updates with context-dependent forgetting, which is well motivated for acute vs. chronic clinical signals.
- **Broad empirical scope.** The paper evaluates on two healthcare datasets and multiple task types: next-event forecasting, insulin prediction, CHF classification, and sepsis prediction.
- **There is evidence that the proposed inference mode helps forecasting.** Across both datasets, the time-specific inference variant consistently outperforms the model’s own autoregressive inference baseline (e.g., PopHR top-10 recall 71.7 vs. 65.5; eICU top-20 recall 69.3 vs. 64.9), suggesting a real practical modeling idea.
- **Results are competitive overall.** TrajGPT is often among the top-performing methods and is best on several zero-shot and forecasting metrics, even if not uniformly dominant on all fully supervised tasks.
- **The paper aims for interpretability beyond pure benchmarking.** The case studies and trajectory/risk visualizations are aligned with a clinically meaningful use case, even though they remain illustrative.

## Weaknesses

###: Fatal
- **The zero-shot classification mechanism is not specified clearly enough to support one of the paper’s central claims.**  
  This is the most serious issue because the paper repeatedly highlights “zero-shot” classification and “without requiring task-specific fine-tuning,” but the methodology never clearly defines how patient-level labels are produced for insulin, CHF, and sepsis in the zero-shot setting. The paper says it “conducted zero-shot classification” and shows AUPRC values in Tables 1–2, and Section 5.1 qualitatively links clustering of sequence representations to zero-shot classification, but it does not describe the actual decision rule, scoring function, or mapping from pretrained outputs/representations to patient-level labels. AUPRC cannot be interpreted without a continuous score, and that score construction is not described. Since zero-shot transfer is a headline claim, this under-specification materially undermines that claim.

- **The time-specific inference rule is under-specified and appears internally inconsistent in the main text.**  
  Section 3.2 states that for forecasting a target time point \((x_{n'}, t_{n'})\), the model computes
  \[
  S_{n'} = D_{\Delta_{t_{n'}, n}} S_n + K_{n'}^\top V_n.
  \]
  As written, \(K_{n'}\) depends on the target token/input at \(n'\), which is exactly what is unknown at prediction time. The paper does not explain how \(K_{n'}\) is obtained for an unseen future event—e.g., from a placeholder token, time query only, or another construction. Because the best forecasting results rely on this time-specific inference, the missing practical definition is not a minor detail; it prevents the reader from verifying what was actually run.

### Major:
- **The comparative claims are confounded by differing pretraining/training paradigms across baselines.**  
  Section 4.4 states that TrajGPT uses next-token pretraining, while “other models without an established pre-training paradigm” are pretrained by masking 40% of timesteps with zeros, and several irregular-time baselines are trained from scratch. This makes it difficult to isolate whether improvements come from the SRA architecture, the time-specific inference rule, or simply a more task-aligned pretraining objective. Given that the paper’s headline claims are comparative (“excels,” “strong zero-shot performance”), this is a substantial limitation.
- **The ODE/continuous-dynamics claims are stronger than what is empirically validated.**  
  The paper claims that interpreting TrajGPT as discretized ODEs “effectively captures the underlying continuous dynamics” and enables interpolation/extrapolation, but the experiments do not directly evaluate interpolation quality or otherwise isolate the benefit of the ODE interpretation itself. The evidence mainly shows that the proposed time-specific inference heuristic improves forecasting over autoregressive rollout. That is useful, but it does not fully validate the broader continuous-dynamics claim.
- **The empirical advantages are often modest and not uniformly dominant across tasks.**  
  Some reported gains are narrow relative to the reported bootstrap standard errors, especially in forecasting. Moreover, TrajGPT is not consistently best in the fully supervised setting: BiTimelyGPT slightly exceeds it on full-data insulin prediction, mTAND is best on fully supervised CHF, and mTAND also surpasses it on fully supervised sepsis. This does not negate the contribution, but it does weaken the stronger framing that TrajGPT broadly “excels” across tasks.
- **The paper’s efficiency claims are theoretical only.**  
  Sections 2 and 3 emphasize linear training and constant-time inference, and contrast against more expensive alternatives such as ContiFormer, but the experiments do not provide wall-clock runtime, memory, or scaling curves. Also, the text simplifies the complexity to \(O(N)\) while the derivation itself uses \(O(Nd^2)\), so the practical efficiency case remains incomplete.

### Minor
- **Ablation evidence is incomplete for a paper making several mechanistic claims.**  
  Table 3 only reports PopHR forecasting top-10 recall, omits classification-task ablations, and contains an incomplete row (“TrajGPT (without Pre-training)” has a missing autoregressive entry “?”). This limits confidence in the claimed roles of pretraining, decay gating, and RoPE beyond a single forecasting metric.
- **Key hyperparameter choices are insufficiently justified.**  
  The temperature parameter \(\tau=20\) directly controls decay behavior, yet there is no sensitivity analysis. Since the model’s central novelty is content-dependent forgetting, this matters.
- **The claimed clinical interpretation of adaptive forgetting is not empirically demonstrated.**  
  Section 3.1 argues that chronic diseases should induce larger \(\gamma_n\) and acute conditions smaller \(\gamma_n\), but the paper does not analyze learned \(\gamma\) values or show that this behavior actually emerges.
- **Dataset construction favors relatively frequent, denser trajectories.**  
  On PopHR, the paper keeps only 194 PheCodes with more than 50,000 occurrences and excludes patients with fewer than 50 records. That may simplify the problem relative to the sparse, long-tail setting where irregular clinical modeling is often hardest.
- **The forecasting metric does not directly test trajectory fidelity or interpolation quality.**  
  Top-\(K\) recall for future codes is reasonable for code recommendation, but it is only an indirect proxy for the paper’s stronger claims about continuous trajectory modeling.
- **Few-shot setup lacks important detail.**  
  The paper reports “few-shot classification with 5 samples” but does not clearly specify whether this means 5 total samples, 5 per class, or some other protocol.

### Trivial
- **Some narrative claims are overstated relative to results.**  
  For example, the conclusion and abstract sometimes imply broad success “without requiring task-specific fine-tuning,” whereas the strongest results are mixed across zero-shot, few-shot, and full fine-tuning settings.
- **The qualitative interpretation evidence is illustrative rather than rigorous.**  
  The case studies are useful, but they do not constitute a strong validation of interpretability or clinical utility on their own.

## Nice-to-Haves
- Add a direct interpolation/imputation benchmark to better validate the continuous-time/ODE framing.
- Provide runtime and memory comparisons to substantiate the efficiency claims.
- Analyze learned decay values \(\gamma_n\) across clinical contexts to test the chronic-vs-acute intuition.
- Expand ablations to classification tasks and both datasets.
- Clarify sensitivity to lookup window size and to \(\tau\).

## Removed Points
These points are flagged to be removed, treat them with caution.

- **Complaint about missing related work such as RetNet/Mamba/EHR foundation models.**  
  I am not including this as a formal weakness because the review instructions explicitly prohibit criticizing missing related work when external confirmation is unavailable. It is fair to say the paper’s novelty should be delimited more carefully, but not to penalize it for omitted citations.
- **Criticism based on entities potentially being unavailable or unverifiable.**  
  Not applicable; removed by instruction if raised.
- **Pure formatting/style issues from the PDF extraction.**  
  For example, parser artifacts, repeated figure captions, and “Fig. ??” are not reliable paper defects in this review setting and should not drive the assessment.
- **“Unfair comparison” arguments where asymmetry favors baselines.**  
  Such points are removed per instruction. The retained fairness concern is specifically about asymmetries that make TrajGPT’s gains harder to interpret.

## Novel Insights
The paper seems stronger as a **task-aligned forecasting model with an interesting irregular-time recurrent attention mechanism** than as a fully validated **continuous-time foundation model**. The most convincing evidence in the submission is not the ODE framing itself, but the consistent empirical advantage of the model’s own time-specific inference over its autoregressive rollout. Conversely, the paper’s most vulnerable claims are exactly the ones that extend beyond that evidence: zero-shot patient-level classification without a clearly defined prediction rule, and continuous-dynamics/interpolation claims without direct validation. In other words, the work likely contains a real modeling contribution, but its current framing overshoots what is actually established.

## Suggestions
- **Precisely define the zero-shot classification pipeline.** State how a patient-level score is produced for insulin/CHF/sepsis, how AUPRC is computed, and whether any calibration/prototypes/logistic heads are used.
- **Fully specify time-specific inference.** In particular, explain how \(K_{n'}\), \(Q_{n'}\), and any input at the target timestep are constructed when the future token is unknown.
- **Tighten the main claims.** Reframe the paper around demonstrated benefits—irregular-time forecasting and strong transfer behavior—unless the stronger ODE and zero-shot claims are fully specified and directly validated.
- **Make comparisons fairer.** Where possible, apply the same next-token pretraining objective to strong pretrained baselines, or include non-pretrained TrajGPT comparisons more comprehensively.
- **Strengthen ablations.** Complete Table 3, include classification tasks, and analyze the effect of \(\tau\), decay gating, and pretraining separately.
- **Add direct tests for the continuous-time story.** An interpolation/imputation task or targeted benchmark would materially strengthen the ODE interpretation.
- **Report empirical efficiency.** Runtime/memory/scaling results would make the complexity claims much more convincing.

## Score and Decision
**Assessment by axis:**  
- **Originality:** Moderate. The content-dependent decay on top of a recurrent/linear-attention style architecture for irregular clinical sequences is a meaningful idea, though the paper does not fully separate architectural novelty from framing.  
- **Importance of the research question:** High. Irregular clinical time-series representation learning is important and practically relevant.  
- **Whether claims are well supported:** Mixed to weak for the headline claims. Some empirical improvements are real, but the strongest claims are undermined by under-specified zero-shot classification and time-specific inference.  
- **Soundness of experiments:** Moderate. The experimental scope is broad, but fairness and specification issues limit interpretability.  
- **Clarity of writing:** Moderate. The paper is readable overall, but key operational details are missing where they matter most.  
- **Value to the research community:** Potentially good if clarified, but in current form the missing methodological specification is too central.

**Calibration against human-reviewed anchors:**  
- I compared this paper primarily against **TimelyGPT** (/home/wg25r/review_agent/human_reviews/2sCcTMWPc2.md; scores 5, 6, 6, 5; reject), which is closely related in topic and also presented a promising irregular-time pretraining architecture with some experimental breadth but insufficiently convincing evidence for broad claims. TrajGPT is similar in overall promise, but the missing specification of both zero-shot classification and time-specific inference is more central than the typical concerns in TimelyGPT, which pushes it slightly lower.  
- I also used **GITAR** (/home/wg25r/review_agent/human_reviews/tkN0sLhb4P.md; scores 3, 6, 5, 5; reject) as a lower-quality irregular-time anchor. TrajGPT is clearly stronger than that level because it has broader experiments and more compelling empirical results.  
- On the higher end, I looked at **Context Clues** (/home/wg25r/review_agent/human_reviews/zg3ec1TdAP.md; accept poster, scores 5, 8, 6, 10, 6) and **Time-to-Event Pretraining for 3D Medical Imaging** (/home/wg25r/review_agent/human_reviews/zcTLpIfj9u.md; accept poster, scores 8, 5, 6). Those accepted papers had clearer experimental framing and, crucially, did not leave their central prediction mechanism underdefined. TrajGPT falls below these acceptance anchors because its main claims depend on unspecified procedures.

Overall, this paper has a real idea and meaningful empirical promise, but the method specification gaps are too central to ignore. I would place it in the **borderline-reject to clear-reject** range, below the stronger accepted empirical medical foundation-model papers and around/slightly below related rejected irregular-time pretraining work.

**Final score: 4.5 / 10**  
**Decision: Reject**

MY FINAL SCORE: <pineapple>4.5</pineapple>
MY FINAL DECISION: <orange>Reject</orange>